Sheetal Medicare Products Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹0(0.00%)
Premium (ELP)
Sheetal Medicare Products Limited's is preparing to launch its Initial Public Offering (IPO) with a substantial issue size of 23,00,400 Shares. The offering comprises a fresh issue component of 21,85,200 Shares.
The price band for the IPO has been set at TBD, providing investors with a range to place their bids. The minimum investment lot consists of TBD, making it accessible to both retail and institutional investors.
The subscription window for this public offering opens on TBD and will conclude on TBD. Following the subscription period, the share allotment is scheduled for TBD, with the official listing expected to commence on TBD on the NSE exchange.
Incorporated in 1997, Sheetal Medicare Products Limited is a healthcare and pharmaceutical company mainly involved in manufacturing ayurvedic, herbal, and medicinal products. The company offers a range of herbal formulations such as oils, syrups, powders, tablets, and other wellness products designed for health and personal care. It focuses on natural and traditional treatment methods by combining ayurvedic practices with modern manufacturing processes to serve the domestic market. The company operates from its manufacturing unit in Maharashtra and continues to work as a small to mid-sized player in the herbal and pharmaceutical segment in India.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
The expected premium is based on market buzz and online information. It should not be considered as the actual listing price or valuation. Always refer to the RHP and seek advice from a financial expert before making any investment decisions.
- Healthcare Product Focus: Operates in pharmaceutical and wellness products, benefiting from steady demand in the healthcare segment.
- Diverse Product Range: Offers multiple products across herbal and healthcare categories, reducing reliance on a single segment.
- Industry Experience: Long presence in the sector supports operational stability and customer trust.
- Limited Scale: Smaller size compared to big pharma companies may restrict growth and market reach.
- High Competition: Faces competition from well-established healthcare and Ayurvedic brands.
- Regulatory Challenges: Subject to strict healthcare regulations, which can impact operations and approvals
- Devendra Somnath Pandya
- Kalpana Devendra Pandya
- Mitesh Devendra Pandya
Sheetal Medicare Products Limited
Bigshare Services Private Limited